Vulnerabilities of PTEN-TP53-deficient prostate cancers to compound PARP-PI3K inhibition. (Q38991113)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Vulnerabilities of PTEN-TP53-deficient prostate cancers to compound PARP-PI3K inhibition.
scientific article

    Statements

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit